• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维纳卡兰不会改变正常和电重构心房的早期复极或收缩性。

Vernakalant does not alter early repolarization or contractility in normal and electrically remodelled atria.

机构信息

Department of Physiology, Faculty of Medicine, Maastricht University, Universiteitssingel 50, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.

出版信息

Europace. 2018 Jan 1;20(1):140-148. doi: 10.1093/europace/eux025.

DOI:10.1093/europace/eux025
PMID:28449044
Abstract

AIMS

Besides the inhibition of the sodium inward current, vernakalant also inhibits the ultra rapid rectifier (IKur) and transient outward current (Ito). Inhibition of these currents increases contractility in canine atrial myocytes and goat atria. We investigated the effect of vernakalant on early repolarization and contractility in normal and electrically remodelled atria.

METHODS AND RESULTS

Goats were implanted a pressure catheter, piezoelectric crystals, and electrodes to obtain atrial contractility and effective refractory period (ERP). The active component in pressure distance loops was used to compute the atrial work index (AWI). Experiments were performed in normal and electrically remodelled atria at clinically relevant plasma levels of vernakalant. As a positive control, the Ito/IKur blocker AVE0118 was investigated. Monophasic action potentials were recorded in anaesthetized goats and in explanted hearts to determine changes in action potential morphology. Vernakalant did not affect atrial work loops during sinus rhythm. Likewise vernakalant did not increase atrial fractional shortening or AWI during pacing with fixed heart rate and AV-delay. In contrast, AVE0118 did increase AWI, with a positive force frequency relation. Both in normal and remodelled atria, vernakalant strongly increased ERP but did not prolong early repolarization.

CONCLUSION

In goat atria, vernakalant does not have an atrial positive inotropic effect and does not affect early repolarization. At high rates vernakalant may even have a negative inotropic effect.

摘要

目的

除了抑制钠离子内流,维纳卡兰还抑制超快速整流电流(IKur)和瞬时外向电流(Ito)。抑制这些电流可增加犬心房肌细胞和山羊心房的收缩力。我们研究了维纳卡兰对正常和电重构心房早期复极和收缩力的影响。

方法和结果

山羊被植入压力导管、压电晶体和电极,以获得心房收缩力和有效不应期(ERP)。主动成分用于计算心房工作指数(AWI)。在临床相关维纳卡兰血浆水平下,在正常和电重构心房中进行实验。以 Ito/IKur 阻滞剂 AVE0118 作为阳性对照进行研究。在麻醉山羊和离体心脏中记录单相动作电位,以确定动作电位形态的变化。在窦性节律期间,维纳卡兰不影响心房工作环。同样,维纳卡兰在固定心率和 AV 延迟起搏时不增加心房分数缩短或 AWI。相比之下,AVE0118 确实增加了 AWI,具有正力频率关系。在正常和重构的心房中,维纳卡兰强烈增加 ERP,但不延长早期复极。

结论

在山羊心房中,维纳卡兰没有心房正性肌力作用,也不影响早期复极。在高心率时,维纳卡兰甚至可能具有负性肌力作用。

相似文献

1
Vernakalant does not alter early repolarization or contractility in normal and electrically remodelled atria.维纳卡兰不会改变正常和电重构心房的早期复极或收缩性。
Europace. 2018 Jan 1;20(1):140-148. doi: 10.1093/europace/eux025.
2
Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.维纳卡兰在电重构山羊心房中的抗心律失常作用是通过减慢传导和延长后除极不应期来实现的。
Heart Rhythm. 2016 Apr;13(4):964-72. doi: 10.1016/j.hrthm.2015.12.009. Epub 2015 Dec 8.
3
Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.维拉卡兰在非重构犬左心房中的速率依赖性作用主要归因于钠通道阻断:与雷诺嗪和 dl-索他洛尔的比较。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):400-8. doi: 10.1161/CIRCEP.111.968305. Epub 2012 Feb 9.
4
Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.AVE0118对慢性房室传导阻滞犬心房的电药理学效应分析:心房复极延迟剂抗心房颤动作用的特征
Heart Vessels. 2020 Sep;35(9):1316-1322. doi: 10.1007/s00380-020-01612-1. Epub 2020 Apr 28.
5
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.新型抗心律失常药物 vernakalant:窦性节律和慢性心房颤动患者心房组织的离体研究。
Cardiovasc Res. 2013 Apr 1;98(1):145-54. doi: 10.1093/cvr/cvt006. Epub 2013 Jan 22.
6
Vernakalant selectively prolongs atrial refractoriness with no effect on ventricular refractoriness or defibrillation threshold in pigs.维纳卡兰选择性地延长心房不应期,对心室不应期或猪的除颤阈值没有影响。
J Cardiovasc Pharmacol. 2011 Mar;57(3):302-7. doi: 10.1097/FJC.0b013e3182073c94.
7
The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.小电导钙激活钾通道抑制剂 NS8593 和 UCL1684 通过心房选择性抑制钠通道活性预防心房颤动的发生。
J Cardiovasc Pharmacol. 2020 Aug;76(2):164-172. doi: 10.1097/FJC.0000000000000855.
8
AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.AVE0118,一种瞬时外向电流(I(to))和超快速延迟整流电流(I(Kur))的阻滞剂,可在山羊房颤复律后完全恢复心房收缩力。
Circulation. 2006 Sep 19;114(12):1234-42. doi: 10.1161/CIRCULATIONAHA.106.630905. Epub 2006 Aug 28.
9
Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.雷诺嗪和维纳卡兰在短QT综合征实验性全心脏模型中预防室性心律失常。
J Cardiovasc Electrophysiol. 2016 Oct;27(10):1214-1219. doi: 10.1111/jce.13029. Epub 2016 Jul 13.
10
Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.新型钾通道阻滞剂AVE0118对麻醉猪心房的影响。
Cardiovasc Res. 2003 Nov 1;60(2):298-306. doi: 10.1016/s0008-6363(03)00543-1.

引用本文的文献

1
The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats.乙酰胆碱激活的钾电流抑制剂XAF-1407可终止山羊的持续性心房颤动。
Front Pharmacol. 2021 Jan 27;11:608410. doi: 10.3389/fphar.2020.608410. eCollection 2020.